Bharat Biotech's Covaxin is 77.8 per cent effective in protecting against COVID-19, according to data from Phase III trials conducted on 25,800 participants across India. Sources said trial data and results were studied and recommended for approval by the DCGI's Subject Expert Committee on Tuesday. The data was submitted to the DCGI over the weekend.
from Videos https://ift.tt/3zM7uNf
Subscribe to:
Post Comments (Atom)
-
No power supply, a looming food and water crisis, more than 3 lakh people displaced and over 1,100 dead - as Israel strikes backs after Hama...
-
By BY JIM TANKERSLEY AND EMILY COCHRANE from NYT Business https://ift.tt/3jGs75O
No comments:
Post a Comment